News
Bloom Science Appoints Medicine Development Expert Dr. Stephen Wright to Clinical Advisory Board
SAN DIEGO, Calif., January 4, 2023 -- Dr. Stephen Wright joins Bloom Science, Inc., a clinical-stage biotechnology company developing novel medicines for neurological diseases and conditions, as a...
Bloom Science to Develop ALS Biotherapeutics with Exclusive Technology License from Yeda, the Technology Transfer Company of Weizmann Institute of Science
SAN DIEGO, Calif., January 4, 2023 -- Bloom Science, Inc., a clinical-stage biotechnology company developing novel medicines for neurological diseases and conditions, and Yeda Research and...
Bloom Science Completes Successful Pre-IND Meeting with the FDA for BL-001 Clinical Trial to Treat Dravet Syndrome
SAN DIEGO, Calif., January 4, 2023 -- Bloom Science, Inc., a clinical-stage biotechnology company developing novel medicines for neurological diseases and conditions, successfully completed a...
Bloom Science to Present Live at Biotech Showcase 2023
SAN DIEGO, Calif., December 17, 2022 -- Bloom Science, Inc. founder & CEO Christopher Reyes, PhD presents live at Biotech Showcase™ 2023 on Tuesday January 10 at 2:45 p.m. PT. Biotech Showcase,...
Harnessing the Gut–Immune–Brain Axis to Treat Disease
How a 100-year-old study spawned a novel class of multifunctional neurological treatments. Read the latest on Bloom Science's epilepsy and ALS lead programs and how a 100-year-old study spawned a...
Bloom Science Raises USD $12 Million in Series A Financing
Bloom Science is developing novel engineered and rationally selected microbiome-based treatments for neurological and inflammatory diseases with initial programs in Drug Resistant Epilepsy and...